Kate Murphy

Four early-career faculty in emergency medicine will receive up to 3 years of K12 funding to support their research and career development.

Dr. Hakam Tiba joins a select team of scientists from the University of Michigan tasked with seeking out and funding innovative research across the Medical School.

Whether it was in the lab or at the drafting table, delivering patient care or developing novel algorithms, Weil Institute core teams and members have made 2024 our most impactful, solution-filled year to date!

Dr. Benjamin Bassin was recognized for his work in developing technologies, interventions and partnerships that improve the care of critically ill and injured patients.

RUA Diagnostics was named one of the Top Ten Most Promising Companies during the 2024 Texas Life Science Forum.

Dr. Robert Dickson and Dr. Hallie Prescott have been installed as the Galen B. Toews, M.D. Legacy Professor and the Toews Family Legacy Professor, respectively, in Pulmonary and Critical Care Medicine.

Fifth Eye, Inc., a spin-off of the Max Harry Weil Institute for Critical Care Research and Innovation, announced the publication of a new study in the peer-reviewed journal, PLOS Digital Health, demonstrating the power of the company’s Analytic for Hemodynamic Instability-Predictive Indicator (AHI-PI) in predicting patient deterioration before a Rapid Response Team (RRT) event. An RRT event occurs when a dedicated team of healthcare professionals is mobilized to respond to a patient's critical deterioration. Detecting patient deterioration early is crucial, as it provides clinicians with more time to intervene, potentially preventing crises, improving patient outcomes, and reducing hospital costs.

In a rapid response to the dire shortage of intravenous (IV) fluid bags currently affecting hospitals nationwide, investigators from the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation and U-M Precision Health have developed a novel projection model to help U-M Health teams conserve critical medical supplies.

InspireRx, LLC., a spin-off company of the University of Michigan (U-M) Max Harry Weil Institute for Critical Care Research and Innovation, received over $2 million in Small Business Innovation Research (SBIR) grants to support further development of the AerosolVE BioHelmet, a compact negative pressure system for patients with highly contagious airborne respiratory infections such as COVID-19.

The Weil Institute will have a major presence at this year's Celebrate Invention event, hosted by U-M Innovation Partnerships. Dr. Kevin Ward, Executive Director of the Institute, will speak as the 2024 Distinguished University Innovator of the Year. Precision Trauma and RUA Diagnostics, two Weil Institute partners, will display a novel tourniquet and breath analysis technology, respectively.

Through a $4.17M NIH grant, a team of biomedical engineers, medical clinicians and data scientists from the Max Harry Weil Institute for Critical Care Research and Innovation is collaboratively researching ways to develop a portable, non-invasive breathalyzer-type device and corresponding algorithm to quickly and accurately diagnose acute respiratory distress syndrome (ARDS).